CRF2R Agonist Treatment Helps Maintain Muscle Mass in Aged and Chronically Ill Animals
Author Information
Author(s): Hinkle Richard T, Lefever Frank R, Dolan Elizabeth T, Reichart Deborah L, Zwolshen Janice M, Oneill Timothy P, Maloney Kris G, Mattson John P, Ferreira Leonardo F, Musch Timothy I, Poole David C, Isfort Robert J
Primary Institution: Procter & Gamble Company
Hypothesis
We hypothesize that treating animals with a CRF2R agonist will maintain skeletal muscle mass and force production in animals with chronic disease and in aged animals.
Conclusion
The study shows that CRF2R agonists can maintain skeletal muscle mass and force production in aged and chronically ill animals.
Supporting Evidence
- Treatment with a CRF2R agonist for up to 3 months resulted in greater muscle force production in aged rats.
- In EMP hamsters, treatment led to greater muscle force production compared to untreated animals.
- CHF rats treated with CRF2R agonists showed increased muscle mass and force production compared to vehicle-treated rats.
Takeaway
Giving a special medicine to older animals and those with chronic illnesses helps keep their muscles strong and healthy.
Methodology
Animal models of aging, congestive heart failure (CHF), and emphysema (EMP) were used to evaluate the effects of CRF2R agonist treatment.
Participant Demographics
Aged rats and hamsters with chronic diseases.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website